Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Symbicort pMDI vs Turbuhaler in Asthma
NCT00536731Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Sep 2007
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of budesonide + formoterol in asthma, sponsored by AstraZeneca. Started Sep 2007; status: completed.
02
Drugs
budesonide + formoterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00536731.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00536731.